OTC market in Central and Eastern Europe 2010

The report analyses in detail the OTC drugs and dietary supplements market in eight countries in the region: Russia, Poland, Ukraine, Romania, the Czech Republic, Hungary, Bulgaria and Slovakia.
It focuses on:

• OTC drugs and dietary supplements market value
• share of OTC in total market and best-selling OTC products
• leading OTC products manufacturers
• non-pharmacy and online sales of OTC products.

It also contains the analysis of distribution channels and provides forecasts up to 2012 for OTC products markets, prepared by PMR’s pharmaceutical and economy experts.

Moreover, the publication shows how the economic crisis affected the OTC market and sales revenues of companies engaged in OTC products sales. The changes in the distribution structure are given as well.

The report answers following questions:

What was the impact of the crisis on the OTC market?
What country has the largest OTC market?
Which OTC market has the highest growth potential?
What are the strategies of the OTC manufacturers?
In which country is the OTC market saturated?
What is the share of OTC products in total pharmacy sales?
Who are the largest wholesalers in particular countries?
What are the largest pharmacy chains?

…and more!

Who will benefit from reading the report?

• the senior management of OTC companies active in the region

• decision makers of OTC companies considering entering the market

• pharmaceutical wholesalers and distributors

• non-pharmacy and on-line drug distributors

• advertising agencies

• research and analytical institutions

• embassies and other government institutions.

Reasons to purchase:

• there is no such report on the market

• it is already the third edition publication

• it provides a comparative analysis of OTC products market in 8 countries – all in one place for a competitive price

• learn more about OTC market value, share of OTC as a proportion of overall market and share of dietary supplements as a proportion of overall market

• develop effective business strategies by understanding the expansion of OTC products portfolio in particular CEE country

identify key market players and distribution channels

Why did we decide to prepare the report?

• there is no such report on the market (which analyses and compared 8 CEE countries)
• aim to show how the economic crisis affected the OTC market in particular countries as well as overall in the region
• aim to show how the economic crisis affected sales revenues of companies which engage in OTC products sales
• aim to show what changes in the distribution structure in particular countries the economic crisis caused

Report strengths

• all information regarding OTC products segment in CEE in one place – for a competitive price
• comparative analysis of OTC product markets in 8 countries
• large scope
• experience from previous 2 editions

When will the report prove useful?

• start of OTC products sales in CEE
• development of OTC product sales in CEE
• analysis of competitors
• analysis of market saturation
• expansion of OTC products portfolio in particular CEE country (the report helps to decide in which)

Key report sections

• best selling OTC drugs
• best selling dietary supplements
• leading OTC drugs manufacturers
• profiles of leading regional OTC products manufacturers
• leading dietary supplements manufacturers
• OTC drugs market value 2006-2012
• dietary supplements market value
• share of OTC in total pharmacy sales
• sales structure of OTC products in pharmacy sales
• sales structure of OTC products in non-pharmacy sales
• regulation regarding non-pharmacy sales of OTC products
• regulations regarding online sales of OTC products
• largest advertisers in the OTC segment
• largest pharmacy chains in particular countries
• largest wholesalers in particular countries
• main events and trends on particular countries
• comparative analysis of OTC market value, share of OTC as a proportion of overall market and share of dietary supplements as a proportion of overall market 

Extract from this report

• According to our estimates, the OTC products market in the CEE region was worth some €9.2bn in 2009, which represented a slight increase of approx. 1% y-o-y in euro terms. A half of this was generated by Russia.
• The OTC product markets in the CEE countries are dominated by large global concerns such as Novartis, GSK and Sanofi-Aventis. There are not many companies of CEE origin which are important players in the whole region analysed. 

Market commentary by expert

Although the OTC products market in Central and Eastern Europe developed by only 1% in 2009, the market growth rate should be much higher during the next three years (2010-2012) and will reach 10% annually on average (CAGR). The OTC products market in the region is not homogenous, varying from Russia and Ukraine, where sales of OTC drugs is restricted to pharmacy outlets only, to Poland and the Czech Republic, where some non-prescription medicines can be sold outside pharmacies and through the internet. There is definitely strong growth potential and development opportunities in the Central and Eastern European region, as the OTC products markets in particular countries are, in most cases, less saturated than, for example, in Western Europe.

Agnieszka Stawarska, Pharmaceutical analyst
Monika Stefanczyk, Head pharmaceutical analyst 

Request sample pages/interactive screenshare

To receive more information on this report, please sign up.

*required

*Would you like a FREE interactive screenshare?		Yes No
*Email:
		To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:		IT, Telecoms Construction Pharma, Healthcare Retail, FMCG Finance, Investments, Banking Consulting, Research, Law Government, Trade Organisations Media, Publications Education, Students Other
		Privacy Policy
		I agree with terms and conditions of PMR Privacy Policy. SUBSCRIBE

1. Report methodology p. 15

2. Executive summary p. 21

3. OTC market in CEE countries p. 23

   • Comparative analysis of OTC markets in CEE region p. 23
     • Share of individual OTC markets in 2009 p. 23
     • Value of OTC market in CEE countries 2007-2012 p. 24
     • Average CAGR for OTC markets in CEE countries 2010-2012 p. 25
   • Russia p. 26
     • Main trends and events on OTC market p. 26
     • OTC market value p. 31
       • OTC market value by distribution channel p. 31
       • OTC market value by product status (drugs vs. dietary supplements) p. 32
       • Share of OTC as a proportion of the pharmaceutical market p. 32
       • Value of OTC drug market in the years 2006-2012 p. 33
       • OTC drugs market by therapeutic category p. 35
       • Value of dietary supplement market p. 35
       • Prices of OTC products p. 36
       • Switch from Rx to OTC p. 37
       • Best selling OTC products p. 37
   • Poland p. 39
     • Main trends and events on OTC market p. 39
     • OTC market value p. 47
       • OTC market value by distribution channel p. 47
       • OTC market value by product status (drugs vs. dietary supplements) p. 48
       • Share of OTC as a proportion of pharmaceutical market p. 49
       • Value of OTC products market in the years 2006-2012 p. 49
       • OTC products market by therapeutic category p. 51
       • Value of dietary supplements market p. 54
     • Prices of OTC products p. 54
     • Switch from Rx to OTC p. 55
     • Best selling OTC products p. 56
   • Ukraine p. 57
     • Main trends and events on OTC market p. 57
     • OTC market value p. 60
       • OTC market value by distribution channel p. 60
       • OTC market value by product status (drugs vs. dietary supplements) p. 60
       • Share of OTC as a proportion of the pharmaceutical market p. 62
       • Value of OTC product market in the years 2006-2012 p. 63
       • Value of dietary supplement market p. 64
     • Prices of OTC products p. 64
     • Switch from Rx to OTC p. 66
     • Best selling OTC products p. 66
   • Czech Republic p. 67
     • Main trends and events on OTC market p. 67
     • OTC market value p. 72
       • OTC market value by distribution channel p. 72
       • OTC drug market by volume p. 73
       • Share of OTC as a proportion of the pharmaceutical market p. 74
       • Value of OTC product market in the years 2006-2012 p. 74
       • OTC product market by therapeutic category p. 75
     • Prices of OTC products p. 75
     • Switch from Rx to OTC p. 76
     • Best selling OTC products p. 76
   • Romania p. 77
     • Main trends and events on the market p. 77
     • OTC market value p. 83
       • OTC market value by distribution channel p. 83
       • OTC market value by product status (drugs vs. dietary supplements) p. 84
       • Share of OTC as a proportion of the pharmaceutical market p. 84
       • Value of OTC products market in the years 2006-2012 p. 85
       • Value of dietary supplement market 2005-2013 p. 86
       • OTC products market by therapeutic category p. 87
       • Prices of OTC products p. 90
       • Switch from Rx to OTC p. 90
       • Best selling OTC products p. 91
   • Hungary p. 92
     • Main trends and events on OTC market p. 92
     • OTC market value p. 98
       • OTC market value by distribution channel p. 98
       • OTC market value by product status (drug vs. dietary supplements) p. 98
       • Share of OTC as a proportion of the pharmaceutical market p. 99
       • Value of OTC product market in the years 2006-2012 p. 99
       • OTC drugs market by therapeutic category p. 100
       • Value of dietary supplement market p. 101
       • Dietary supplement market by therapeutic categories p. 101
     • Prices of OTC products p. 102
     • Switch from Rx to OTC p. 103
     • Best selling OTC products p. 104
   • Bulgaria p. 104
     • Main trends and events on OTC market p. 104
     • OTC market value p. 108
       • OTC market value by distribution channel p. 108
       • OTC market value by product status (drugs vs. dietary supplements) p. 110
       • Share of OTC as a proportion of the pharmaceutical market p. 110
       • OTC drugs market value in the years 2006-2012 p. 111
       • OTC drugs market by therapeutic categories p. 112
     • Prices of OTC products p. 112
     • Switch from Rx to OTC p. 113
     • Best selling OTC products p. 114
       • OTC drugs p. 114
       • Dietary supplements p. 116
   • Slovakia p. 117
     • Main trends and events on OTC market p. 117
     • OTC market value p. 118
       • OTC market value by distribution channel p. 118
       • Share of OTC as a proportion of the pharmaceutical market p. 118
       • Value of OTC product market in the years 2006-2012 p. 119
       • OTC product market by therapeutic category p. 119
     • Prices of OTC products p. 120
     • Switch from Rx to OTC p. 120
     • Best selling OTC products p. 121

4. Advertising of OTC products in CEE countries p. 123

   • General trends p. 123
   • Russia p. 124
     • Legal framework p. 124
     • Spending on OTC advertising p. 124
   • Poland p. 126
     • Legal framework p. 126
     • Spending on OTC advertising p. 127
   • Ukraine p. 130
     • Legal framework p. 130
     • Spending on advertising p. 131
   • Czech Republic p. 134
     • Legal framework p. 134
     • Spending on advertising p. 135
   • Romania p. 137
     • Legal framework p. 137
     • Spending on OTC advertising p. 138
   • Hungary p. 138
     • Legal framework p. 138
     • Spending on OTC advertising p. 139
   • Bulgaria p. 140
     • Legal framework p. 140
     • Spending on OTC advertising p. 141
   • Slovakia p. 142
     • Legal framework p. 142
     • Spending on advertising p. 143

5. Key manufacturers p. 145

   • Profiles of selected local manufacturers on OTC market in CEE p. 145
   • Key players in selected CEE countries p. 165
     • Russia p. 165
     • Poland p. 166
     • Ukraine p. 168
     • Czech Republic p.169
     • Romania p. 169
     • Bulgaria p. 171
     • Slovakia p. 173

6. Distribution p. 175

   • Russia p. 175
     • Pharmaceutical wholesalers p. 175
       • Segment profile p. 175
       • Selected key players p. 177
     • Pharmacy distribution p. 182
       • Segment profile p. 182
       • Selected key players p. 183
     • Non-pharmacy sales p. 193
     • Online sales p. 194
   • Poland p. 194
     • Pharmaceutical wholesalers p. 194
       • Segment profile p. 194
       • Selected key players p. 196
     • Pharmacy distribution p. 201
       • Segment profile p. 201
       • Selected key players p. 202
     • Non-pharmacy sales p. 206
     • Online sales p. 208
   • Ukraine p. 210
     • Pharmaceutical wholesalers p. 210
       • Segment profile p. 210
       • Selected key players p. 211
     • Pharmacy distribution p. 216
       • Segment profile p. 216
       • Selected key players p. 218
     • Non-pharmacy sales p. 222
     • Online sales p. 222
   • Czech Republic p. 223
     • Pharmaceutical wholesalers p. 223
       • Segment profile p. 223
       • Selected key players p. 223
     • Pharmacy distribution p. 228
       • Segment profile p. 228
       • Selected key players p. 230
     • Non-pharmacy sales p. 233
     • Online sales p. 236
   • Romania p. 237
     • Pharmaceutical wholesalers p. 237
       • Segment profile p. 237
       • Selected key players p. 237
     • Pharmacy distribution p. 245
       • Segment profile p. 245
       • Selected key players p. 247
     • Non-pharmacy sales p. 257
     • Online sales p. 257
   • Hungary p. 259
     • Pharmaceutical wholesalers p. 259
       • Segment profile p. 259
       • Selected key players p. 259
     • Pharmacy distribution p. 263
       • Segment profile p. 263
       • Selected key players p. 264
       • Non-pharmacy sales p. 267
       • Online sales p. 267
   • Bulgaria p. 268
     • Pharmaceutical wholesalers p. 268
       • Segment profile p. 268
       • Selected key players p. 269
     • Pharmacy distribution p. 274
       • Segment profile p. 274
       • Selected key players p. 276
     • Drugstores p. 278
     • Non-pharmacy sales p. 279
     • Online sales p. 280
   • Slovakia p. 280
     • Pharmaceutical wholesalers p. 280
       • Segment profile p. 280
       • Selected key players p. 281
     • Pharmacy distribution p. 285
       • Segment profile p. 285
       • Selected key players p. 286
     • Non-pharmacy sales p. 289
     • Online sales p. 289
   • Comparative analysis of distribution in CEE p. 290
     • Non-pharmacy sales p. 290
     • Number of pharmacy outlets p. 291

7. Factors influencing OTC market in CEE countries p. 293

   • Macroeconomic and demographic indicators p. 293
     • Macroeconomic overview p. 293
       • GDP growth p. 293
       • Inflation rates p. 296
       • Unemployment rates p. 297
       • Wage levels p. 298
     • Demographic indicators p. 299
       • Population p. 299
       • Urbanisation p. 299
   • Trends in consumer behaviour p. 300
     • OTC intake p. 300
     • Factors which influence OTC purchase p. 301
     • Sport and other physical activity p.307
     • Smoking prevalence p. 309
   • Internet use p. 310
   • Epidemiological trends p. 310
     • Life expectancy at birth p. 310
     • Weight problems p. 311
     • Alcohol consumption p. 312

8. List of graphs p. 315

9. List of tables p. 325

10. About PMR p. 327

11. Contact PMR p. 328

List of graphs

1. Value (€ bn) and y-o-y change of the OTC products market in CEE, 2007-2012
2. Share of individual OTC markets as a proportion of total OTC market in CEE, 2009
3. Value (€ bn) and y-o-y change of the OTC products market in CEE, 2007-2012
4. Average CAGR for the analysed CEE countries for years 2010-2012
5. Market share of drugs and dietary supplements on the pharmacy market for liver protection products in Russia, by value and volume, Q1-Q3 2009
6. Market share of XXX and OTC products on the out-of-the-customer’s pocket pharmacy market for weight loss products in Russia, by value and volume, January-October 2009
7. Share of dietary supplements in the out-of-the-customer’s-pocket pharmacy market of external anti-inflammatory products in Russia, by value and volume, January-October 2009
8. Breakdown of XXX’s dietary supplement sales, by category, 2009
9. XXX’s best-selling dietary supplement brands (RUB m), June 2010
10. Pharmacy sales of OTC products in Russia, by product status, 2009
11. Share of OTC drugs as a proportion of the Russian pharmaceutical market, by value, 2009
12. Share of OTC drugs as a proportion of the Russian out-of-the-pocket drug market, by value and volume, 2008-H1 2010
13. Value (€ bn) and y-o-y change in the OTC drug market in Russia, 2006-2012
14. OTC drug market in Russia, by main product categories (€ m), 2009
15. Average prices of OTC drugs per package in Russia ($), 2002-Q1 2010
16. Average prices of dietary supplements per package in Russia ($), 2008-Q1 2010
17. Top 10 best-selling OTC drugs in Russia, by sales value, 2009
18. Top 10 best-selling dietary supplements in Russia, by sales value, 2009
19. Number of influenza cases (million) in Poland, 1970-January-September 2010
20. Sales of new OTC products and XXX drugs in Poland (PLN m), 2007-2009
21. Sales of new OTC products and XXX drugs in Poland (number of packages, in millions), 2007-2009
22. Sources of growth on the OTC drug market in Poland, 2009
23. Financial results of XXX (PLN m), H1 2009 and H1 2010
24. Share of sales values of XXX on main markets (%), H1 2010
25. XXX financial results (PLN m) in Poland, 2008-2010
26. OTC product market in Poland, by sales channel, 2009
27. Pharmacy sales of OTC products in Poland, by product status, 2009
28. Non-pharmacy sales of OTC products in Poland, by product status, 2009
29. Total sales of OTC products in Poland, by product status, 2009
30. Share of OTC drugs as a proportion of the Polish pharmaceutical market, by value, 2009
31. Value (€ m) and y-o-y change in the OTC product market in Poland, 2006-2012
32. OTC drugs market in Poland, by sales channel, 2009
33. OTC product market in Poland, by main product categories (€ m), 2009
34. OTC product market in Poland, by main product categories, value share and y-o-y growth, 2009
35. Sales of OTC anti-smoking preparations in Poland (PLN m), 2007-2009
36. Value (PLN m) and y-o-y change in the dietary supplement market in Poland, 2005-2012
37. Average prices of OTC products per package and y-o-y change in Poland (PLN), 2002-January-August 2010
38. Average margins on non-reimbursed products and y-o-y change in Poland, 2005-January-August 2010
39. Most popular cold preparation brands in Poland, July 2008-June 2009
40. Most popular gastric preparation brands in Poland, July 2008-June 2009
41. Neurovitan’s share of the Vitamin B-complexes with minerals category in Ukraine, by volume and value, Q1 2008, Q1 2009 and Q1 2010
42. Pharmacy sales of OTC products in Ukraine, by product status (UAH m), 2007-2009
43. Pharmacy sales of OTC products in Ukraine, by product status ($ m), 2007-2009
44. Pharmacy OTC product market in Ukraine ($ m), by quarter, and y-o-y increase, Q1 2009-Q2 2010
45. Pharmacy sales of OTC products in Ukraine, by product status (million packages), 2007-2009
46. Share of OTC drugs as a proportion of the Ukrainian pharmaceutical market, by value, 2009
47. Value ($ m) and y-o-y change in the OTC products market in Ukraine, 2006-2012
48. XXX dietary supplements market in Ukraine, by sales channel, 2009
49. Average prices of OTC drugs per package in Ukraine (UAH), 2006-2009
50. Average prices of cosmetics per package in Ukraine (UAH), 2006-Q1 2010
51. Average prices of dietary supplements per package in Ukraine (UAH), 2006-Q1 2010
52. Proportion of Czechs buying toiletries, cosmetics and OTC drugs at drugstores (%), 2000-2008
53. Sales of pseudoephedrine-based OTC drugs in the Czech Republic (million packages), 2000-2009
54. Number of authorised OTC medicines in the Czech Republic, 2004-2009
55. OTC products market in the Czech Republic, by sales channel, 2009
56. Number of OTC drug packages sold in the Czech Republic (million), 2007-Q1 2010
57. Share of OTC products as a proportion of the Czech pharmaceutical market, by value, 2009
58. Value (€ m) and y-o-y change in the OTC products market in the Czech Republic, 2006-2012
59. OTC product market in the Czech Republic, by main product categories (€ m), 2009
60. Top five best-selling OTC restricted medicines in the Czech Republic, by volume, 2009
61. Methods of combating headaches in Romania, 2010
62. Most common location of headaches in Romania, 2010
63. Results for influential factors when buying dietary supplements in Romania (score on the Likert scale), 2010
64. Number of products withdrawn from the market in Romania, by product status, 2009
65. Dietary supplement market in Romania, by sales channel, 2009
66. Sales of OTC products in Romania, by product status, 2009
67. Share of OTC products as a proportion of the Romanian pharmaceutical market, by value, 2009
68. XXX share of OTC products as a proportion of the Romanian pharmaceutical market, in rural and urban areas, 2009
69. Value (€ m) and y-o-y change in the OTC products market in Romania, 2006-2012
70. Value (€ m) and y-o-y growth in the dietary supplement market in Romania, 2005-2013
71. OTC drugs market in Romania, by main product categories (€ m), 2009
72. Shares of dietary supplement categories in Romania, by sales volume, 2009
73. Shares of dietary supplement categories in Romania, by sales value, 2009
74. Percentage of people who buy dietary supplements in Hungary, by age, 2009
75. Sources of information, prior to purchase, on OTC drugs and dietary supplements in Hungary, 2010
76. Amount of money spent per purchase on vitamins in Hungary (HUF), by sales channel, January-September 2009
77. Vitamin sales in Hungary by form, by value, January-September 2009
78. Dietary supplement market in Hungary, by sales channel, January-September 2009
79. Share of OTC products as a proportion of the Hungarian pharmaceutical market, by value, 2009
80. Value (€ m) and y-o-y change in the OTC products market in Hungary, 2006-2012
81. OTC drugs market in Hungary, by main product categories (€ m), 2009
82. Dietary supplement market in Hungary, by main products categories, by volume, July 2008-June 2009
83. Dietary supplement market in Hungary, by main products categories, by value, November 2008-October 2009
84. Percentage change of OTC drugs prices in Hungary (y-o-y), Q1 2006-Q3 2009
85. Most prevalent illnesses in Bulgaria, 2009
86. Estimate of OTC product market in Bulgaria, by sales channel, 2009
87. XXX pharmacy sales of OTC products in Bulgaria, by product status, 2009
88. XXX non-pharmacy sales of OTC products in Bulgaria, by product status, 2009
89. XXX total sales of OTC products in Bulgaria, by product status, 2009
90. XXX share of OTC drugs as a proportion of the Bulgarian pharmaceutical market, by value, 2009
91. Value (€ m) and y-o-y change in the OTC drugs market in Bulgaria, 2006-2012
92. OTC drugs market in Bulgaria, by sales channel, 2009
93. OTC drug market in Bulgaria, by main product categories (€ m), 2009
94. Market share of best selling OTC drugs in pharmacy sales in Bulgaria, by value, 2009
95. Market share of best-selling OTC drugs in Bulgaria, by volume, 2009
96. Market share of best-selling dietary supplements in pharmacy sales in Bulgaria, by value, 2009
97. Share of OTC drugs as a proportion of the Slovak pharmaceutical market, by value, 2009
98. Value (€ m) and y-o-y change in the OTC products market in Slovakia, 2006-2012
99. OTC product market in Slovakia, by main product categories (€ m), 2009
100. Leading 5 advertisers of drugs and parapharmaceuticals in Poland, by amount spent (PLN m), Q1-Q3 2007-Q1-Q3 2009
101. Selected leading radio advertisers of drugs in Poland, by amount spent, 2009
102. Selected top brands of OTC products in terms of TV advertising in Poland, by amount spent (PLN m), September 2009-January 2010
103. Number of OTC product promotions in promotional retail magazines in Poland, by product category, 2008 and 2009
104. Spending on TV advertising on XXX by XXX in Poland (PLN m) and y-o-y change, 2005-Q1 2010
105. Total spending on drug advertising in Ukraine (UAH m) and y-o-y change, January-July 2008-2010
106. Breakdown of spending on drug advertising in Ukraine, by advertising channel, January-July 2010
107. Breakdown of spending on TV drug advertising in Ukraine, by TV channel, January-July 2010
108. 10 leading TV advertisers of OTC drugs in Ukraine, by amount spent, January-July 2010
109. Top 10 brands of OTC drugs in Ukraine in terms of TV advertising spending, by amount spent, January-July 2010
110. Total spending on OTC product advertising in the Czech Republic (€ m), 2008-2009
111. XXX organisation chart, 2010
112. XXX global revenues and net profit (€ m), 2005-2010
113. XXX global sales, by region, 2009
114. XXX sales in selected CEE countries (€ m), 2009 and H1 2010
115. XXX global OTC sales, by product groups, 2009
116. XXX global sales revenues (€ m) and y-o-y change, 2005-H1 2010
117. XXX global pharmaceuticals sales, by country, 2009
118. XXX sales revenues and net profit (€ m), 2004-H1 2010
119. Share of OTC products as a proportion of XXX sales revenues, 2009
120. Top 10 XXX OTC brands, by value, 2009
121. XXX global revenues and net profit (€ m), 2007-H1 2010
122. XXX export sales, by country and region, 2009
123. Share of OTC products as a proportion of XXX’s domestic revenues, 2009
124. XXX global sales revenues and net profit (€ m), 2004-2009
125. XXX global turnover (€ m) and y-o-y change, 2002/2003-2008/2009
126. XXX turnover (€ m) and y-o-y change in Romania, 2006-2010
127. Top 10 manufacturers of OTC drugs in Russia, by sales value, Q1 2010
128. Top 10 manufacturers of dietary supplements in Russia, by sales value, 2009
129. Top 20 manufacturers of OTC products in Poland, by value, September 2008-August 2009
130. Top manufacturers of vitamin products and analgesics in Poland, by value, 2009
131. Top 10 manufacturers of dietary supplements in Ukraine, by sales value, 2009
132. Top manufacturers of analgesics in Romania, Q1 2010
133. Top manufacturers of dietary supplements in Romania, by sales value, 2009
134. Top 10 manufacturers of OTC drugs in Bulgaria, by sales value, 2009
135. Top 10 manufacturers of dietary supplements in Bulgaria, by sales value, 2009
136. Share of OTC products as a proportion of the sales value of pharmaceutical distributors in Russia, by category of wholesaler, 2009
137. Concentration of pharmaceutical wholesale in Russia, 2005-2009
138. Market share of largest pharmaceutical wholesalers in Russia, by sales value to pharmacies, 2009
139. XXX turnover ($ bn) and y-o-y change in Russia, 2006-H1 2010
140. 107. XXX turnover ($ bn) and y-o-y change in Russia, 2006-2009
141. XXX turnover ($ bn) and y-o-y change in Russia, 2006-2009
142. XXX turnover ($ bn) and y-o-y change in Russia, 2007-2009
143. XXX turnover ($ m) and y-o-y change in Russia, 2007/2008-2009/2010
144. Share of non-pharmaceuticals as a proportion of the sales value of pharmacy chains in Russia, by category of pharmacy chain, 2009
145. Selected largest pharmacy chains in Russia, by number of outlets, 2009
146. Market share of selected largest pharmacy chains as a proportion of the pharmacy market in Russia, by sales value, 2009
147. Market share of top 10 pharmacy chains in Russia, by sales value, 2003-2009
148. XXX pharmacy chain expansion in Russia (number of units), 2003-2009
149. XXX sales revenues ($ m) and y-o-y change in Russia, 2004-Q1 2010
150. Share of OTC products as a proportion of XXX sales revenues in Russia, Q3 2009
151. XXX sales revenues ($ m) and y-o-y change in Russia, 2006-H1 2009
152. XXX turnover ($ m) and y-o-y change in Russia, 2007-2009
153. XXX turnover ($ m) and y-o-y change in Russia, 2007-2009
154. XXX turnover ($ m) and y-o-y change in Russia, 2007-2009
155. XXX turnover ($ m) and y-o-y change in Russia, 2008-2009
156. XXX turnover ($ m) and y-o-y change in Russia, 2006-2009
157. XXX turnover ($ m) and y-o-y change in Russia, 2007-2009
158. Market share of largest pharmaceutical wholesalers market in Poland, by sales value to pharmacies, H1 2010
159. XXX sales revenues (€ m) and y-o-y change in Poland, 2006-H1 2010
160. Sales structure of XXX in Poland, by subsidiaries, H1 2010
161. XXX group sales revenues (€ m) and y-o-y change in Poland, 2006-H1 2010
162. XXX sales revenues (€ m) and y-o-y change in Poland, 2006-H1 2010
163. Sales structure of the XXX, by division, 2009
164. XXX wholesale revenues (€ m) and y-o-y change in Poland, 2006-H1 2010
165. Number of pharmacies and pharmacy outlets in Poland (’000), 1990-May 2010
166. Selected largest pharmacy chains in Poland, by number of outlets, September 2010
167. XXX retail sales revenues in Poland (€ m) and y-o-y change, 2006-H1 2010
168. Revenues and net profit/loss of XXX in Poland (€ m), 2004-2008
169. Revenues and net profit/loss of XXX in Poland (€ m), 2003-2008
170. Where did you buy medicines, personal care products, medical devices, etc. in 2009?
171. Most popular medicines and supplements sought in internet pharmacies in Poland in May 2010
172. Share of foreign and domestic medicines as a proportion of the sales value of leading pharmaceutical wholesalers in Ukraine, 2009
173. Market share of largest pharmaceutical wholesalers in Ukraine, by sales value, 2009
174. XXX turnover ($ m) and y-o-y change in Ukraine, 2006-2009
175. XXX turnover ($ m) and y-o-y change in Ukraine, 2006-2009
176. XXX Ukraine turnover ($ m) and y-o-y change in Ukraine, 2006-2009
177. XXX turnover ($ m) and y-o-y change in Ukraine, 2006-2009
178. XXX turnover ($ m) and y-o-y change in Ukraine, 2007-2009
179. XXX turnover ($ m) and y-o-y change in Ukraine, 2006-2009
180. Pharmacy outlets in Ukraine by category of outlet, 2010
181. Number of pharmacies cooperating with specific numbers of wholesalers in Ukraine, 2008 and 2009
182. Market share of selected largest pharmacy chains as a proportion of the pharmacy market in Ukraine, by sales value, Q1-Q3 2009
183. Market share of top 10 pharmacy chains in Ukraine, by city, Q1-Q3 2009
184. Selected largest pharmacy chains in Ukraine, by number of outlets, Q1-Q3 2009
185. Sales structure of XXX, by product group by volume, 2010
186. Number of pharmacies operated by XXX in Ukraine, 1997-2010
187. Market shares of largest players on the pharmaceutical wholesale market in the Czech Republic, by sales to pharmacies and hospitals, January 2010
188. XXX sales revenues (€ m) and y-o-y change in the Czech Republic, February 2005-January 2009
189. XXX sales revenues (€ m) and y-o-y change in the Czech Republic, April 2006-March 2010
190. XXX sales revenues (€ m) and y-o-y change in the Czech Republic, 2005-2009
191. Sales revenues (€ m) of Ceska lekarnicka distribution companies in the Czech Republic, 2009
192. XXX sales revenues (€ m) and y-o-y change in the Czech Republic, 2006-H1 2010
193. Number of pharmacy outlets in the Czech Republic and y-o-y change, 2000-Q1 2010
194. Number of new pharmacies and pharmacy points opened in the Czech Republic, 2006-2009
195. Selected largest pharmacy chains in the Czech Republic, by number of pharmacies, August 2010
196. Spontaneous and assisted recall of the names of pharmacy chains in the Czech Republic, June 2009
197. Revenues and net profit/loss of Europharm in the Czech Republic (€ m), 2006-January 2009
198. XXX sales revenues (€ m) and y-o-y change in the Czech Republic, 2006-H1 2010
199. Number of OTC medicines available outside pharmacies in the Czech Republic, 2004-August 2010
200. Do you think that medicines should be available at outlets other than pharmacies in the Czech Republic? October 2009
201. Main advantages of non-pharmacy sales of medicines according to respondents in the Czech Republic, October 2009
202. Main disadvantages of non-pharmacy sales of medicines according to respondents in the Czech Republic, October 2009
203. Market shares of largest players on the pharmaceutical wholesale market in Romania, by sales value to pharmacies and hospitals, 2009
204. XXX sales revenues (€ m) and y-o-y change in Romania, 2003-H1 2010
205. Share of OTC products as a proportion of XXX’ sales revenues in Romania, 2009
206. XXX sales revenues (€ m) and y-o-y change in Romania, 2006-Q1 2010
207. XXX sales revenues (€ m) and y-o-y change in Romania, 2007-2009
208. XXX sales revenues (€ m) and y-o-y change in Romania, 2007-2009
209. XXX turnover (€ m) and y-o-y change in Romania, 2002-2009
210. XXX sales revenues (€ m) and y-o-y change in Romania, 2006-2010
211. XXX share of OTC drugs as a proportion of XXX sales revenues in Romania, 2009
212. XXX sales revenues (€ m) and y-o-y change in Romania, 2002-2009
213. XXX sales revenues (€ m) and y-o-y change in Romania, 2002-2009
214. Monthly sales revenues of pharmacies in Romania, 2009
215. Selected largest pharmacy chains in Romania, by number of outlets, September 2010
216. Sales structure of XXX sales in Romania, by pharmacy locations, 2009
217. XXX sales revenues (€ m) and y-o-y change in Romania, 2003-H1 2010
218. Sales structure of XXX in Romania, by product groups, 2009
219. XXX sales revenues (€ m) and y-o-y change in Romania, 2007-2009
220. XXX sales revenues (€ m) and y-o-y change in Romania, 2007-2009
221. XXX sales revenues (€ m) from wholesale and retail activity and y-o-y change in Romania, 2007-2009
222. XXX sales revenues (€ m) and y-o-y change in Romania, 2002-2009
223. XXX sales revenues (€ m) and y-o-y change in Romania, 2007-H1 2010
224. Sales structure of XXX in Romania, by product groups, 2009
225. XXX’s shares in specific OTC subgroups in Romania, 2008-2009
226. XXX OTC products with the highest sales growth figures in Romania, 2009
227. XXX sales revenues (€ m) and y-o-y change in Romania, 2006-2010
228. Sales structure of XXX in Romania, by product groups, 2009
229. XXX sales revenues (€ m) and y-o-y change in Romania, 2003-H1 2010
230. XXX market shares of selected largest players on the pharmaceutical wholesale market in Hungary, by sales to pharmacies and hospitals, January 2010
231. XXX sales revenues (€ m) and y-o-y change in Hungary, 2006-2009
232. XXX sales revenues (€ m) and y-o-y change in Hungary, 2006/2007-2009/2010
233. Number of pharmacy outlets in Hungary, by category, September 2010
234. Selected largest pharmacy chains in Hungary, by number of outlets, August 2010
235. Market shares of largest players on the pharmaceutical wholesale market in Bulgaria, 2009
236. Number of XXX Trading clients (pharmacies and hospitals), January 2007, 2008, 2009 and 2010
237. XXX Trading sales revenues (€ m) and y-o-y change in Bulgaria, 2007-H1 2010
238. XXX turnover (€ m) and y-o-y change in Bulgaria, 2007-2009
239. XXX (€ m) turnover and y-o-y change in Bulgaria, 2007-2009
240. XXX turnover (€ m) and y-o-y change in Bulgaria, 2006-2009
241. Number of pharmacies in Bulgaria and y-o-y change, 2008-2010
242. Selected largest pharmacy chains in Bulgaria, by number of outlets, 2010
243. Market shares of largest players on the pharmaceutical wholesale market in Slovakia, by sales to pharmacies, 2008
244. XXX sales revenues (€ m) and y-o-y change in Slovakia, February 2005-January 2010
245. XXX sales revenues (€ m) and y-o-y change in Slovakia, 2004-2009
246. XXX sales revenues (€ m) and y-o-y change in Slovakia, 2005-2009
247. XXX sales revenues (€ m) and y-o-y change in Slovakia, 2004-2008
248. Selected largest pharmacy chains in Slovakia, by number of outlets, September 2010
249. XXX revenues (€ m) and y-o-y change in Slovakia, 2007-2009
250. XXX sales revenues (€ m) and y-o-y change in Slovakia, 2007-2009
251. Mean population to pharmacy ratio in selected CEE countries, 2010
252. Real GDP growth rate (%) in selected CEE countries, 2006-2012
253. Total GDP in CEE countries (€ bn) and y-o-y change, 2006-2012
254. GDP of CEE countries (€ bn, %), 2009
255. GDP per capita based on PPP in selected CEE countries ($), 2009
256. HCPI in selected CEE countries (%), 2006-H1 2010
257. Unemployment rates in selected CEE countries, 2006-H1 2010
258. Average gross monthly wages in selected CEE countries (€), 2006-H1 2010
259. Population in selected CEE countries, 2009
260. Population living in urban areas in selected CEE countries, 2009
261. Medicine consumption at first sign of a minor ailment, in selected CEE countries, 2009
262. Main reasons for refraining from taking medicine at the first sign of a minor ailment in selected CEE countries, 2009
263. Factors influencing OTC medicine purchase: knowledge that a medicine works in selected CEE countries in comparison with European average, 2009
264. Factors influencing purchase of OTC medicines: pharmacist’s advice in selected CEE countries in comparison with European average, 2009
265. 231. Factors which influence OTC medicine purchase: frequent use of a specific product in selected CEE countries in comparison with European average, 2009
266. Factors influencing OTC medicine purchase: confidence in a product in selected CEE countries in comparison with European average, 2009
267. Factors influencing OTC medicine purchase: safety of medicines in selected CEE countries in comparison with European average, 2009
268. Factors influencing OTC medicine purchase: medicine’s rapid action in selected CEE countries in comparison with European average, 2009
269. Factors influencing purchase of OTC medicines: medicine’s price in selected CEE countries in comparison with European average, 2009
270. Factors influencing OTC medicine purchase: product familiarity in selected CEE countries in comparison with European average, 2009
271. Factors influencing OTC medicine purchase: a medicine’s value for money in selected CEE countries in comparison with the European average, 2009
272. Factors influencing OTC medicine purchase: trusted name in selected CEE countries in comparison with European average, 2009
273. Factors influencing OTC medicine purchase: ease of ingesting selected CEE countries in comparison with European average, 2009
274. Factor’s influencing OTC medicine purchases: advertising of medicine in selected CEE countries in comparison with European average, 2009
275. Frequency of exercising or playing sport in selected CEE countries in comparison with EU average, 2009
276. Frequency of engaging in physical activity other than sport in CEE countries in comparison with EU average, 2009
277. Incidence of smoking among adult males and females (% of population) in CEE countries, 2008
278. Internet users in the CEE countries analysed (% of adult population), Q2 2010
279. Male life expectancy at birth in selected CEE countries, 1990 and 2008
280. Female life expectancy at birth in selected CEE countries, 1990 and 2008
281. Adults of more than 15 years of age who are obese in selected CEE countries, 2000-2009
282. Incidence of alcohol consumption in CEE in comparison with EU average, last 12 months, 2009
283. Incidence of alcohol consumption in selected CEE countries, by country, by incidence, 2009
284. Amount of alcohol drunk in selected CEE countries, by country, by amount, 2009

List of tables

1. Annual average exchange rates used for this report (euro to national currency unit), 2006-2009
2. Value and volume of OTC drugs market in Russia, 2009
3. Value and volume of dietary supplements pharmacy market in Russia, 2009
4. Sales of painkillers in Poland, 2002-1011
5. Top five best-selling Vitamin B-complexes in Ukraine, by value, Q1 2010
6. Selected best-selling OTC drugs in Ukraine, by value, 2009
7. Selected best-selling OTC drugs in Ukraine, by value, H1 2010
8. Best-selling OTC products in the Czech Republic, wholesale sales, by volume, Q1 2010
9. Dietary supplements market in Romania, by main products categories, 2009
10. Share of OTC and XXX drugs in specific price categories in Romania, by value and by volume, 2009
11. Top 10 best selling OTC drugs in Romania, by sales value, H1 2007, H1 2008 and H1 2009
12. Top 10 best selling analgesics in Romania, by sales value, 2009-Q1 2010
13. Selected best selling dietary supplements in ATC categories in Romania, by value, 2009
14. Average amount spent by a person in Hungary on dietary supplements, medicines, herbal medicines and bioproducts, 2009
15. Average prices of best-selling OTC drugs per package in Bulgaria, 2009
16. Average prices of best-selling dietary supplements per package in Bulgaria, 2009
17. Top 10 best-selling OTC drugs in Bulgaria, by sales value, 2009
18. Top 10 best-selling OTC drugs in Bulgaria, by sales volume, 2009
19. Top 10 best-selling dietary supplements in Bulgaria, by sales value, 2009
20. Best-selling OTC drugs in Slovakia, by sales value, H1 2010
21. Selected leading advertisers of OTC drugs in Russia, by number of advertisements, Q1 2009 and Q1 2010
22. Selected most frequently advertised brands of OTC products in Russia, by number of advertisements, Q1 2009 and Q1 2010
23. Leading advertisers of OTC products in the Czech Republic, by amount spent, 2008-2009
24. TV advertising spending in the OTC subgroup in the Czech Republic, by brand, 2009
25. Out-of-home TV advertising spending in the OTC subgroup in the Czech Republic, by brand, 2009
26. Radio advertising spending in the OTC subgroup in the Czech Republic, by brand, 2009
27. Cinema advertising spending in the OTC subgroup in the Czech Republic, by brand, 2009
28. 10 top brands of OTC drugs in terms of TV advertising spending in Hungary, by amount spent, 2008-2009
29. Selected new OTC brands with the highest TV advertising spending figures in Hungary, 2009
30. Leading TV advertisers of OTC brands in Hungary, by amount spent, 2009
31. Leading TV advertisers of OTC brands in Hungary, by amount spent, Q1 2010
32. Leading TV advertisers of OTC products in Bulgaria, by amount spent, 2009
33. Leading TV advertisers of OTC products in Bulgaria, by amount spent, H1 2010
34. Data on SUKL activity in the arena of drug advertising in Slovakia, 2007-2009
35. Selected leading advertisers of OTCs in Slovakia, by amount spent (€), selected months in 2009 and 2010
36. Selected leading advertisers of OTC products in Slovakia, by amount spent, 2009 and H1 2010
37. Top 10 manufacturers of dietary supplements in Ukraine, sales value, volume and y-o-y changes, 2009
38. Top 10 manufacturers of OTC products in the Czech Republic, by sales value, 2009
39. Top 15 OTC drug manufacturers in Romania by sales revenues (€ m), 2010
40. Top 10 manufacturers of OTC drugs in Bulgaria, sales value and volume, 2009
41. Top 10 manufacturers of dietary supplements in Bulgaria, sales value and volume, 2009
42. Top 5 manufacturers of OTC drugs in Slovakia, by sales value, 2009
43. Most popular medicines in the web search engine in Romania, spring 2010
44. Comparison of alternative OTC product distribution channels in selected CEE countries, 2010

Actavis
Bayer
Berlin-Chemie/Menarini
Boehringer Ingelheim
Diod
Evalar
Gedeon Richter
GlaxoSmithKline
Johnson&Johnson
Krka
Novartis
Ozone Laboratories/ LaborMed
Pharmstandard
Ratiopharm
Reckitt Benckiser
Sandoz
Sopharma
US Pharmacia
Walmark
Wyeth
Zentiva/Sanofi-Aventis

and more...